Literature DB >> 11853074

Magnification of the pore size in biodegradable collagen sponges.

M Kuberka1, D von Heimburg, H Schoof, I Heschel, G Rau.   

Abstract

In tissue engineering cells are often combined with a carrying structure with collagen being a suitable material to form a 3D-scaffold. A process to manufacture collagen sponges with an adjustable and homogeneous structure has been developed at the Helmholtz-Institute. Using this process, collagen suspensions are frozen directionally and subsequently vacuum-dried. One clinical application in which these scaffolds can be used is soft tissue reconstruction. Various soft tissue defects require an adequate replacement, e.g. in the case of severe burn wounds, or after tumour resections. Collagen (type I) sponges, which are cultured with preadipocytes, may be used to regenerate such defects. In this case, pore sizes of approximately 100 microm are desired to allow a complete differentiation of preadipocytes into adipocytes. Based on known technology to manufacture collagen sponges with an adjustable and homogeneous pore structure, research on the increase of pore size beyond the previous limit of 40 microm was necessary in order to enable soft tissue replacement. A scaffold with an average pore size of 100 microm was obtained.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11853074     DOI: 10.1177/039139880202500111

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  9 in total

1.  Anisotropic freeze-cast collagen scaffolds for tissue regeneration: How processing conditions affect structure and properties in the dry and fully hydrated states.

Authors:  Prajan Divakar; Kaiyang Yin; Ulrike G K Wegst
Journal:  J Mech Behav Biomed Mater       Date:  2018-09-25

2.  The effect of PLGA sphere diameter on rabbit mesenchymal stem cells in adipose tissue engineering.

Authors:  Yu Suk Choi; Si-Nae Park; Hwal Suh
Journal:  J Mater Sci Mater Med       Date:  2007-11-28       Impact factor: 3.896

3.  Development and ultra-structure of an ultra-thin silicone epidermis of bioengineered alternative tissue.

Authors:  Quenton Wessels; Etheresia Pretorius
Journal:  Int Wound J       Date:  2013-07-09       Impact factor: 3.315

4.  Effect of pore size and cross-linking of a novel collagen-elastin dermal substitute on wound healing.

Authors:  Bouke K H L Boekema; Marcel Vlig; Leon Olde Damink; Esther Middelkoop; Lizette Eummelen; Anne V Bühren; Magda M W Ulrich
Journal:  J Mater Sci Mater Med       Date:  2013-11-01       Impact factor: 3.896

5.  Fluorescence-activated cell sorting of PCK-26 antigen-positive cells enables selection of ovine esophageal epithelial cells with improved viability on scaffolds for esophagus tissue engineering.

Authors:  Kristina Kofler; Herwig Ainoedhofer; Michael E Höllwarth; Amulya K Saxena
Journal:  Pediatr Surg Int       Date:  2010-01       Impact factor: 1.827

Review 6.  Bladder biomechanics and the use of scaffolds for regenerative medicine in the urinary bladder.

Authors:  Fatemeh Ajalloueian; Greg Lemon; Jöns Hilborn; Ioannis S Chronakis; Magdalena Fossum
Journal:  Nat Rev Urol       Date:  2018-02-13       Impact factor: 14.432

7.  3D differentiation of neural stem cells in macroporous photopolymerizable hydrogel scaffolds.

Authors:  Hang Li; Asanka Wijekoon; Nic D Leipzig
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

8.  Use of a novel collagen matrix with oriented pore structure for muscle cell differentiation in cell culture and in grafts.

Authors:  V Kroehne; I Heschel; F Schügner; D Lasrich; J W Bartsch; H Jockusch
Journal:  J Cell Mol Med       Date:  2008-01-11       Impact factor: 5.310

9.  A biomaterial with a channel-like pore architecture induces endochondral healing of bone defects.

Authors:  A Petersen; A Princ; G Korus; A Ellinghaus; H Leemhuis; A Herrera; A Klaumünzer; S Schreivogel; A Woloszyk; K Schmidt-Bleek; S Geissler; I Heschel; G N Duda
Journal:  Nat Commun       Date:  2018-10-25       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.